tiprankstipranks
Trending News
More News >
Lifeway Foods (LWAY)
NASDAQ:LWAY

Lifeway Foods (LWAY) AI Stock Analysis

Compare
165 Followers

Top Page

LW

Lifeway Foods

(NASDAQ:LWAY)

71Outperform
Lifeway Foods' strong revenue growth and solid balance sheet are significant strengths. However, cash flow challenges and high valuation pose risks. Recent corporate achievements add positive sentiment. Overall, the stock presents a balanced outlook with potential growth tempered by financial management challenges.
Positive Factors
Market Expansion
The company is expanding its SKUs into the high-growth RTD market with new on-trend flavors which we believe will introduce the brand to new customers.
Product Popularity
Lifeway's flagship kefir product saw revenue growth of 14% in Q4’24 and 20% in FY24, demonstrating the brand's strength and consumer interest in functional foods like probiotics.
Revenue Growth
Double-digit revenue growth is expected to continue on a full-year basis, supported by tapering milk prices and modest GM expansion.
Negative Factors
Financial Impact
GAAP earnings were skewed by year-end bonuses and expenses associated with the unsolicited takeover attempt by Danone.
Operational Costs
Elevated SG&A costs in FY24 were associated with legal/advisory fees due to the unsolicited Danone acquisition and other shareholder actions.
Revenue Miss
Q3’24 revenue growth of 13% missed our 18% estimate and moved down $3M sequentially as Q2’24 results appear to have uniquely benefited from club channel distribution, while GMs were compressed on elevated milk prices.

Lifeway Foods (LWAY) vs. S&P 500 (SPY)

Lifeway Foods Business Overview & Revenue Model

Company DescriptionLifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; cupped kefir and Icelandic Skyr, a line of strained kefir and yogurt products; and frozen kefir in soft serve and pint-size containers. It sells its products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was founded in 1986 and is based in Morton Grove, Illinois.
How the Company Makes MoneyLifeway Foods generates revenue through the sale of its products across multiple distribution channels, including retail stores, health food outlets, and direct-to-consumer online platforms. The company's key revenue streams are derived from its flagship kefir products, which are available in various forms and flavors to cater to a wide range of consumer preferences. Additionally, Lifeway Foods benefits from strategic partnerships and distribution agreements that help expand its market reach domestically and internationally. The company's earnings are significantly influenced by its ability to maintain product quality, drive innovation in new product development, and respond to consumer trends towards healthier eating options.

Lifeway Foods Financial Statement Overview

Summary
Lifeway Foods has demonstrated strong revenue growth and maintains a robust balance sheet with minimal leverage. However, cash flow management poses challenges, with zero free cash flow in 2024 and declining cash flow ratios, indicating a need for improved cash generation.
Income Statement
85
Very Positive
Lifeway Foods has demonstrated strong revenue growth, increasing from $93.66 million in 2019 to $186.82 million in 2024. The company has maintained a healthy gross profit margin, reaching 26% in 2024, indicating efficient cost management. However, the net profit margin has seen some fluctuations, dropping to 4.8% in 2024 from 7.1% in 2023, which suggests potential challenges in controlling non-operating expenses. The EBIT and EBITDA margins also reflect strong operational performance, with 7.4% each in 2024.
Balance Sheet
90
Very Positive
Lifeway Foods maintains a robust balance sheet, evidenced by a low debt-to-equity ratio of 0.001 in 2024, indicating minimal leverage and financial risk. The equity ratio stands at 79.4%, demonstrating significant equity financing. Return on equity has remained solid at 12.5% in 2024, although it has declined from 18.8% in 2023, suggesting some pressure on profitability relative to shareholders' equity.
Cash Flow
60
Neutral
Lifeway Foods' cash flow performance shows areas for improvement. The operating cash flow to net income ratio was 0 in 2024, down from 1.49 in 2023, indicating challenges in converting income into cash. Free cash flow was also zero in 2024, impacted by capital expenditures and investing activities. The company needs to focus on enhancing cash generation and managing capital expenditures effectively.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
186.82M160.12M141.57M119.06M102.03M
Gross Profit
48.57M42.44M26.79M28.71M26.93M
EBIT
13.85M17.00M2.35M5.88M4.92M
EBITDA
13.85M20.20M5.08M8.61M8.19M
Net Income Common Stockholders
9.03M11.37M924.00K3.31M3.23M
Balance SheetCash, Cash Equivalents and Short-Term Investments
16.73M13.20M4.44M9.23M7.93M
Total Assets
90.55M81.65M69.00M70.87M60.07M
Total Debt
117.00K2.92M6.68M7.46M3.11M
Net Debt
-16.61M-10.27M2.23M-1.77M-4.81M
Total Liabilities
18.64M21.22M21.43M21.74M13.21M
Stockholders Equity
71.91M60.44M47.57M49.13M46.85M
Cash FlowFree Cash Flow
6.26M12.59M538.00K3.64M4.49M
Operating Cash Flow
12.96M16.94M3.99M5.56M6.38M
Investing Cash Flow
-6.68M-4.41M-4.03M-7.14M-1.89M
Financing Cash Flow
-2.75M-3.78M-4.75M2.88M-405.00K

Lifeway Foods Technical Analysis

Technical Analysis Sentiment
Positive
Last Price23.71
Price Trends
50DMA
22.79
Positive
100DMA
22.99
Positive
200DMA
22.03
Positive
Market Momentum
MACD
0.09
Positive
RSI
53.28
Neutral
STOCH
53.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LWAY, the sentiment is Positive. The current price of 23.71 is above the 20-day moving average (MA) of 23.64, above the 50-day MA of 22.79, and above the 200-day MA of 22.03, indicating a bullish trend. The MACD of 0.09 indicates Positive momentum. The RSI at 53.28 is Neutral, neither overbought nor oversold. The STOCH value of 53.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LWAY.

Lifeway Foods Risk Analysis

Lifeway Foods disclosed 20 risk factors in its most recent earnings report. Lifeway Foods reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Lifeway Foods Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$360.01M39.9713.64%16.67%-20.96%
69
Neutral
$248.13M70.2916.69%19.41%-43.88%
64
Neutral
$9.01B14.733.76%178.62%3.83%6.05%
64
Neutral
$227.72M30.504.98%2.03%-47.76%
58
Neutral
$506.49M-6.77%-5.50%89.98%
LSLSF
49
Neutral
$60.25M-13.68%26.50%82.92%
45
Neutral
$263.52M-19.41%-6.68%-9.71%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
LWAY
Lifeway Foods
23.68
-0.32
-1.33%
NATR
Nature's Sunshine Products
12.28
-7.10
-36.64%
STKL
SunOpta
4.16
-1.32
-24.09%
HAIN
Hain Celestial
2.92
-4.03
-57.99%
MAMA
Mama's Creations
6.71
0.33
5.17%
LSF
Laird Superfood
5.85
3.51
150.00%

Lifeway Foods Earnings Call Summary

Earnings Call Date:Mar 14, 2025
(Q3-2024)
|
% Change Since: 16.11%|
Next Earnings Date:May 19, 2025
Earnings Call Sentiment Positive
The earnings call reflected a strong positive sentiment driven by consistent sales growth, improved profit margins, and successful product and market expansions. While there are challenges such as increased capital spending and macroeconomic pressures, the highlights significantly outweigh the lowlights.
Q3-2024 Updates
Positive Updates
Record-Breaking Sales Growth
Lifeway Foods reported net sales of $46.1 million for Q3 2024, a 12.7% increase compared to Q3 2023, marking the 20th consecutive quarter of sales growth and the second highest quarterly net sales ever.
Sustained Year-to-Date Growth
For the first 9 months of 2024, net sales totaled $139.9 million, an 18.5% increase from the same period in 2023, and a 98.4% increase compared to 2019.
Gross Profit Margin Improvement
The gross profit margin was 25.7% for Q3 2024 and 26.2% for the first 9 months of 2024, up 30 basis points from 2023.
Product Expansion and Innovation
New product launches include 100% lactose-free labeled products and new flavors like Hot Honey and Matcha Latte. Expansion in distribution includes new placements at Walmart stores and international markets like South Africa and Dubai.
Expanding International Market Presence
Lifeway Foods expanded its distribution network to South Africa and announced new market entry in Dubai and the UAE.
Negative Updates
Increased Capital Spending
Capital spending increased by $2.2 million to $5.4 million for the first 9 months of 2024 compared to the same period in 2023, reflecting planned increases to meet demand.
Macroeconomic and Geopolitical Challenges
Consumers are facing macroeconomic headwinds including higher prices, high interest rates, and an uncertain geopolitical landscape.
Company Guidance
During the Lifeway Foods Q3 2024 earnings call, CEO Julie Smolyansky highlighted the company's impressive performance, noting a 12.7% increase in net sales to $46.1 million, marking the 20th consecutive quarter of growth. This achievement was driven by a strong demand for their flagship drinkable kefir products. The company reported a gross profit margin of 25.7% for the quarter and 26.2% for the first nine months of 2024, reflecting a 30 basis point improvement from the previous year. Net income reached $3 million, with earnings per share of $0.20 per basic and $0.19 per diluted share. Lifeway Foods also increased its capital spending by $2.2 million, totaling $5.4 million to enhance manufacturing capacity. The company continues to focus on strategic sales and marketing investments, contributing to a 22% year-to-date increase in drinkable kefir sales. Smolyansky emphasized the company's ongoing product innovation, distribution expansion, and commitment to providing high-quality, nutritious offerings to meet consumer demand amidst macroeconomic challenges.

Lifeway Foods Corporate Events

Business Operations and StrategyFinancial Disclosures
Lifeway Foods Achieves Record Weekly Sales Growth
Positive
Apr 30, 2025

On April 29, 2025, Lifeway Foods announced a significant achievement of surpassing $5 million in gross sales for the week ending April 27, 2025, marking a 35% increase from the previous year. This milestone highlights the growing demand for Lifeway’s kefir and farmer cheese products, potentially strengthening the company’s market position and signaling positive implications for stakeholders ahead of their first quarter 2025 financial results announcement on May 13, 2025.

Spark’s Take on LWAY Stock

According to Spark, TipRanks’ AI Analyst, LWAY is a Outperform.

Lifeway Foods exhibits strong financial performance with notable revenue growth and a solid balance sheet, yet faces challenges in cash flow management. The technical analysis suggests moderate upward momentum, although the lack of comprehensive momentum indicators adds uncertainty. The company appears overvalued, with no dividend yield to entice income-focused investors. The recent corporate event involving a gain from an investment sale adds a positive note, contributing to a balanced overall stock score.

To see Spark’s full report on LWAY stock, click here.

Legal Proceedings
Lifeway Foods Addresses Misstatements in Press Release
Neutral
Feb 14, 2025

On February 14, 2025, Lifeway Foods’ legal counsel addressed a letter to Edward and Ludmila Smolyansky’s counsel regarding alleged misstatements and omissions they made in a press release. The letter clarifies that the Board of Directors, not the Compensation Committee, discussed Julie Smolyansky’s retention bonus, and Julie was not involved in the decision-making process. The letter emphasizes that the allegations of a proxy war involving the company are unfounded and that the issues in question are personal family matters unrelated to the company’s operations. It also addresses the claim about the independence of directors and the sale of Edward’s shares, attributing the latter’s failure to sell shares to his own actions rather than the company’s interference.

M&A Transactions
Lifeway Foods to Gain $5M from Simple Mills Sale
Positive
Feb 11, 2025

On February 11, 2025, Lifeway Foods announced it expects to gain approximately $5 million from the sale of Simple Mills to Flowers Foods, following its early investment in Simple Mills in 2015. This transaction, pending regulatory approval and expected to close in the first quarter of 2025, will bring Lifeway’s total proceeds from this investment to around $6.5 million. The company congratulated Simple Mills and reaffirmed its support for its CEO, Julie Smolyansky, who was instrumental in the initial investment decision.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.